• Something wrong with this record ?

Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT

M. Dubova, M. Sedivcova, M. Michal, B. Kokoskova, A. Ryska, D. Smid, O. Daum,

. 2015 ; 30 (2) : 223-232. [pub] 20140910

Language English Country Spain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc16000630

Grant support
NT14227 MZ0 CEP Register

Loss of expression of beta subunit of succinate dehydrogenase (SDHB) was proved to be present in a subgroup of KIT/PDGFRA wt gastrointestinal stromal tumors (GISTs). To evaluate possible diagnostic utility of SDHB immunohistochemistry in the differential diagnostics of mesenchymal tumors of gastrointestinal tract (GIT), 11 cases of KIT/PDGFRA wt GISTs, 12 gastric schwannomas (GSs), 20 solitary fibrous tumors (SFTs), 4 leiomyomas (LMs), 16 leiomyosarcomas (LMSs), 5 synovial sarcomas (SSs), 3 endometrioid stromal sarcomas (ESSs), and 1 ileal inflammatory myofibroblastic tumor (IMT) were investigated for SDHB immunoexpression together with molecular genetic analysis of genes encoding succinate dehydrogenase (SDH). Three recent cases of KIT/PDGFRA mutant GISTs were used as controls. Among the 11 KIT/PDGFRA wt GISTs, 6 expressed SDHB, 1 of them harboring a sequence change of SDHD. All SDHB-negative cases were SDHB-D wt. In 1 of the control GIST cases molecular genetic analysis revealed an SDHD sequence change in addition to a mutation in KIT exon 11. No SFT was truly SDHB-negative, but in 2 of them the staining was impossible to analyze. Furthermore, 1 SFT carried an SDHB and another 1 SDHD sequence change. All GSs, LMs, LMSs, SSs, ESSs, and IMT were SDHB-positive or non-analyzable, and SDHB-D wt. Additional factors may play a role in regulating expression of SDHB. Furthermore, SDHB immunohistochemistry alone may be misleading in excluding tumors other than GIST (especially SFT) in the differential diagnosis of KIT/PDGFRA wt mesenchymal tumors of GIT.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16000630
003      
CZ-PrNML
005      
20191023154720.0
007      
ta
008      
160108s2015 sp f 000 0|eng||
009      
AR
024    7_
$a 10.14670/hh-30.223 $2 doi
035    __
$a (PubMed)25205505
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sp
100    1_
$a Daumová, Magdaléna $u Sikl's Department of Pathology, Medical Faculty Hospital, Charles University, Plzen, Czech Republic. $7 xx0228260
245    10
$a Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT / $c M. Dubova, M. Sedivcova, M. Michal, B. Kokoskova, A. Ryska, D. Smid, O. Daum,
520    9_
$a Loss of expression of beta subunit of succinate dehydrogenase (SDHB) was proved to be present in a subgroup of KIT/PDGFRA wt gastrointestinal stromal tumors (GISTs). To evaluate possible diagnostic utility of SDHB immunohistochemistry in the differential diagnostics of mesenchymal tumors of gastrointestinal tract (GIT), 11 cases of KIT/PDGFRA wt GISTs, 12 gastric schwannomas (GSs), 20 solitary fibrous tumors (SFTs), 4 leiomyomas (LMs), 16 leiomyosarcomas (LMSs), 5 synovial sarcomas (SSs), 3 endometrioid stromal sarcomas (ESSs), and 1 ileal inflammatory myofibroblastic tumor (IMT) were investigated for SDHB immunoexpression together with molecular genetic analysis of genes encoding succinate dehydrogenase (SDH). Three recent cases of KIT/PDGFRA mutant GISTs were used as controls. Among the 11 KIT/PDGFRA wt GISTs, 6 expressed SDHB, 1 of them harboring a sequence change of SDHD. All SDHB-negative cases were SDHB-D wt. In 1 of the control GIST cases molecular genetic analysis revealed an SDHD sequence change in addition to a mutation in KIT exon 11. No SFT was truly SDHB-negative, but in 2 of them the staining was impossible to analyze. Furthermore, 1 SFT carried an SDHB and another 1 SDHD sequence change. All GSs, LMs, LMSs, SSs, ESSs, and IMT were SDHB-positive or non-analyzable, and SDHB-D wt. Additional factors may play a role in regulating expression of SDHB. Furthermore, SDHB immunohistochemistry alone may be misleading in excluding tumors other than GIST (especially SFT) in the differential diagnosis of KIT/PDGFRA wt mesenchymal tumors of GIT.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a dítě $7 D002648
650    _2
$a DNA nádorová $x genetika $7 D004273
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gastrointestinální stromální tumory $x diagnóza $x enzymologie $x genetika $7 D046152
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mezoderm $x patologie $7 D008648
650    _2
$a lidé středního věku $7 D008875
650    _2
$a protoonkogenní proteiny c-kit $x genetika $x metabolismus $7 D019009
650    _2
$a růstový faktor odvozený z trombocytů - receptor alfa $x genetika $x metabolismus $7 D020796
650    _2
$a sukcinátdehydrogenasa $x genetika $x metabolismus $7 D013385
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Šedivcová, Monika $u Biopticka laborator s.r.o., Plzen, Czech Republic. $7 xx0215746
700    1_
$a Michal, Michal, $u Sikl's Department of Pathology, Medical Faculty Hospital, Charles University, Plzen, Czech Republic. $d 1959- $7 jn20001103501
700    1_
$a Vaňková, Bohuslava $u Sikl's Department of Pathology, Medical Faculty Hospital, Charles University, and Biopticka laborator s.r.o., Plzen, Czech Republic. $7 xx0258705
700    1_
$a Ryška, Aleš, $u The Fingerland Department of Pathology, University Hospital, Hradec Kralove, Czech Republic. $d 1970- $7 nlk20020124969
700    1_
$a Šmíd, David, $u Surgical Clinic, Medical Faculty Hospital, Charles University, Plzen, Czech Republic. $d 1979- $7 xx0213331
700    1_
$a Daum, Ondřej, $u Sikl's Department of Pathology, Medical Faculty Hospital, Charles University, and Biopticka laborator s.r.o., Plzen, Czech Republic. DAUM@fnplzen.cz. $d 1974- $7 xx0063668
773    0_
$w MED00005439 $t Histology and histopathology $x 1699-5848 $g Roč. 30, č. 2 (2015), s. 223-232
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25205505 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20191023155155 $b ABA008
999    __
$a ok $b bmc $g 1102911 $s 924836
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 30 $c 2 $d 223-232 $e 20140910 $i 1699-5848 $m Histology and histopathology $n Histol Histopathol $x MED00005439
GRA    __
$a NT14227 $p MZ0
LZP    __
$a Pubmed-20160108

Find record

Citation metrics

Archiving options